A Win For VIVUS, Inc.

Wed, Feb 05, 2020 at 05:30 PM
A Win For VIVUS, Inc.

VIVUS, Inc. (VVUS:NASDAQ) jumped higher at $3.38, a gain of 47%. The stock appeared on our News Catalysts scanner on Wed 05 Feb 20 at 08:09 AM in the 'RECOMMENDATION' category. From Tue 14 Jan 20, the stock recorded 42.86% Up Days and 40.00% Green Days

The share price of the company has been moving sideways in recent weeks.

About VIVUS, Inc. (VVUS:NASDAQ)

VIVUS Incis a biopharmaceutical company engaged in the development and commercialization of therapeutic products for large underserved markets. Its product line includes Qsymia for sleep apnea, STENDRA for erectile dysfunction.

Share
Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.